---
layout: minimal-medicine
nav_exclude: true
title: Liposomal Amphotericin B
---

# Liposomal Amphotericin B

**Generic Name:** Liposomal Amphotericin B (various brand names exist, including Ambisome, Abelcet)


**Usage:** Liposomal amphotericin B is an antifungal medication used to treat serious fungal infections, particularly those caused by *Candida* species, *Aspergillus* species, and other fungi resistant to conventional amphotericin B.  It's often reserved for patients who have not responded to or cannot tolerate conventional amphotericin B (deoxycholate).  Specific uses include:

* Invasive aspergillosis
* Candidiasis (including candidemia and other systemic infections)
* Cryptococcosis
* Histoplasmosis
* Mucormycosis
* Other serious fungal infections resistant to other antifungals

**Side Effects:** While generally better tolerated than conventional amphotericin B, liposomal amphotericin B can still cause side effects, though often less severe. These can include:

* **Infusion-related reactions:** Fever, chills, nausea, vomiting, headache, hypotension (low blood pressure)
* **Kidney problems (nephrotoxicity):** Although less common than with conventional amphotericin B, it can still occur, especially with high doses or prolonged treatment.  Regular monitoring of kidney function is essential.
* **Liver problems (hepatotoxicity):** Less common but possible, requiring liver function monitoring.
* **Low blood counts (anemia, thrombocytopenia, leukopenia):** Suppression of bone marrow function can occur.
* **Allergic reactions:**  Rare but possible.


**How it Works:** Liposomal amphotericin B is a formulation of amphotericin B encapsulated within liposomes (tiny spheres of fat). This encapsulation reduces the drug's toxicity while maintaining its antifungal activity.  It works by binding to ergosterol, a component of fungal cell membranes. This binding disrupts the fungal cell membrane, leading to cell death.  The liposomal formulation reduces the interaction of the amphotericin B with mammalian cells, thereby lessening the side effects associated with conventional amphotericin B.


**FAQs:**

* **Is liposomal amphotericin B better than conventional amphotericin B?**  Generally, yes, because it is less nephrotoxic (less harmful to the kidneys).  However, it may not be as effective against certain fungal infections. The choice between the two depends on the patient's condition and response to treatment.

* **How is liposomal amphotericin B administered?** It's typically administered intravenously (IV) over several hours.

* **How long is the treatment course?** The duration of treatment varies depending on the severity and type of infection, and is determined by the physician.

* **What are the monitoring requirements during treatment?** Regular monitoring of kidney function (blood tests), liver function tests, and complete blood counts are crucial during treatment.

* **Are there drug interactions?** Yes, potential drug interactions exist.  It's essential to inform the physician of all medications being taken.

* **Can I take liposomal amphotericin B while pregnant or breastfeeding?** Use during pregnancy and breastfeeding should be carefully considered by a physician, weighing the benefits against potential risks to the mother and child.  It's generally avoided unless absolutely necessary.


**Disclaimer:** This information is for educational purposes only and should not be considered medical advice.  Always consult a healthcare professional for diagnosis and treatment of any medical condition.  The information provided here is not exhaustive and may not cover all aspects of liposomal amphotericin B.


**Note:** This information is AI-generated or crowd-sourced and may not be accurate. Please consult a medical professional for verified advice.